This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Carefusion 303, Inc., Carefusion Corporation. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Kevin O'Brien: Innovator in Infusion Technology
Introduction
Kevin O'Brien is a notable inventor based in Thurles, Ireland. He has made significant contributions to the field of medical technology, particularly in infusion systems. With a total of 4 patents to his name, O'Brien's work focuses on enhancing the efficiency and safety of fluid delivery in medical settings.
Latest Patents
O'Brien's latest patents include the "Ultrasonic Infusion Monitor" and the "Infusion Management System." The Ultrasonic Infusion Monitor is a system and method for detecting a flow rate using ultrasound. This innovative device features a disposable conduit section and a reusable sensor chassis designed to measure the flow rate of a fluid passing through the conduit. The system utilizes ultrasonic transmission, which is reflected off the inner surface of the conduit before being received by the second transducer, ensuring accurate flow rate measurements.
The Infusion Management System involves a master infusion device that receives fluid delivery protocols from a server. This system allows for the configuration of multiple slave infusion pumps, each set with specific fluid delivery protocols. The method ensures that fluids are delivered accurately and efficiently to users, enhancing patient care.
Career Highlights
Kevin O'Brien is currently employed at CareFusion 303, Inc., where he continues to develop innovative solutions in the medical technology sector. His work has been instrumental in advancing infusion technology, making it safer and more effective for healthcare providers.
Collaborations
O'Brien has collaborated with notable colleagues, including Maurice James Hennessy and Ronald Hidalgo. Their combined expertise has contributed to the successful development of advanced medical devices.
Conclusion
Kevin O'Brien's contributions to infusion technology through his patents and work at CareFusion 303, Inc. highlight his commitment to improving patient care. His innovative solutions are paving the way for advancements in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile